Product NDC: | 44087-0022 |
Proprietary Name: | REBIF |
Non Proprietary Name: | INTERFERON BETA-1A |
Active Ingredient(s): | 22 ug/.5mL & nbsp; INTERFERON BETA-1A |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 44087-0022 |
Labeler Name: | EMD Serono, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103780 |
Marketing Category: | BLA |
Start Marketing Date: | 20020307 |
Package NDC: | 44087-0022-3 |
Package Description: | 12 SYRINGE, GLASS in 1 CARTON (44087-0022-3) > .5 mL in 1 SYRINGE, GLASS |
NDC Code | 44087-0022-3 |
Proprietary Name | REBIF |
Package Description | 12 SYRINGE, GLASS in 1 CARTON (44087-0022-3) > .5 mL in 1 SYRINGE, GLASS |
Product NDC | 44087-0022 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | INTERFERON BETA-1A |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20020307 |
Marketing Category Name | BLA |
Labeler Name | EMD Serono, Inc. |
Substance Name | INTERFERON BETA-1A |
Strength Number | 22 |
Strength Unit | ug/.5mL |
Pharmaceutical Classes | Interferon-beta [Chemical/Ingredient],Recombinant Human Interferon beta [EPC],Recombinant Proteins [Chemical/Ingredient] |